Arbor Biotechnologies
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- arbor.bio
- Total Funding
- $304.5M
- Last Round
- $73.9M Series CMar 2025
About
Develops next-generation gene editing therapeutics for genetic diseases, advancing liver and CNS programs into clinic.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account